Dr Jeffrey Scot Meyer, MD | |
Womack Army Medical Center, Ft Bragg, DC 28310 | |
(910) 907-6000 | |
Not Available |
Full Name | Dr Jeffrey Scot Meyer |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | Womack Army Medical Center, Ft Bragg, District Of Columbia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184673873 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 0101236296 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey Scot Meyer, MD 2083 Broadman Ave, Fayetteville, NC 28304 Ph: () - | Dr Jeffrey Scot Meyer, MD Womack Army Medical Center, Ft Bragg, DC 28310 Ph: (910) 907-6000 |
News Archive
The American Association of Community Colleges (AACC) and Phi Theta Kappa Honor Society, with the generous support of METI and L-3 Communications, Inc., have announced the first 25 recipients of the Frank Lanza Memorial Scholarship Program. The scholarships recognize the accomplishments of students enrolled in allied health programs offered by regionally accredited community colleges. Twenty-five students received scholarships of $1,000 each.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).
Media outlets report on how the health overhaul interacts with Medicaid and whether it will ultimately have a positive or negative impact on states.
A promising study out today in the prestigious Journal of Neurosciences showed that in a mouse model of Rett syndrome, researchers were able to reverse abnormalities in brain activity and improve neurological function by treating the animals with an FDA-approved anesthesia drug, ketamine.
› Verified 5 days ago